Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes
Angika Bhasym(Manipal Academy of Higher Education), Prasenjit Guchhait(Regional Centre for Biotechnology), Bahadur Singh Gurjar(National Institute of Immunology), Vineeta Bal(Indian Institute of Science Education and Research Pune), Himanshi Saini(All India Institute of Medical Sciences), Gopal Kumar Patidar(All India Institute of Medical Sciences), Mamta Puraswani(All India Institute of Medical Sciences), Anna George(Hoshi University), Priyadarshini Chatterjee(Regional Centre for Biotechnology), Arvind Bagga(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Aditi Sinha, Poonam Coshic(All India Institute of Medical Sciences), Savit B. Prabhu(Christian Medical College, Vellore), Priyanka Khandelwal(Chacha Nehru Bal Chikitsalaya), Savita Saini(All India Institute of Medical Sciences), Satyajit Rath(National Institute of Immunology)
Cited by 8
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203